James V. Cassella, Chief Development Officer at CONCERT PHARMACEUTICALS, INC. (CNCE), sold 20,212 shares at $8.35 ($169K) on 2023-01-30, disclosed to the SEC on 2023-01-31.
Open-market sale of $169k CNCE by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.35 | 10,106 | $84K | 50.0% |
| 2 | $8.35 | 10,106 | $84K | 50.0% |
| Total | $8.35 avg | 20,212 | $169K | 100% |
| Filing → |
| CNCE | SELL | 2022-02-16 | $12K | — | Filing → |
| CNCE | SELL | 2022-01-07 | $9K | — | Filing → |
| CNCE | SELL | 2021-08-17 | $27K | — | Filing → |